Iron deficiency in critically ill patients: Highlighting the role of hepcidin

Critical Care

Volumn 15, Issue 2, 2011, Pages

  Heming, Nicholas ^a   Montravers, Philippe ^a   Lasocki, Sigismond ^b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b UNIVERSITÉ D'ANGERS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; FERROPORTIN; HEMOGLOBIN; HEPCIDIN; INTERLEUKIN 6; IRON; PROTOPORPHYRIN ZINC; TRANSFERRIN RECEPTOR; ANTIMICROBIAL CATIONIC PEPTIDE; BIOLOGICAL MARKER;

CRITICALLY ILL PATIENT; ERYTHROCYTE; FERRITIN BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRON BLOOD LEVEL; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; IRON METABOLISM; IRON THERAPY; MORTALITY; PRIORITY JOURNAL; RETICULOCYTE HEMOGLOBIN CONTENT; REVIEW; ALGORITHM; CRITICAL ILLNESS; METABOLISM;

ALGORITHMS; ANEMIA, IRON-DEFICIENCY; ANTIMICROBIAL CATIONIC PEPTIDES; BIOLOGICAL MARKERS; CRITICAL ILLNESS; HUMANS; IRON;

EID: 79953020047     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc9992     Document Type: Review

References (49)

1. Clark SF. Iron deficiency anemia. Nutr Clin Pract 2008, 23:128-141. 10.1177/0884533608314536, 18390780.
2. Patterson AJ, Brown WJ, Powers JR, Roberts DC. Iron deficiency, general health and fatigue: results from the Australian Longitudinal Study on Women's Health. Qual Life Res 2000, 9:491-497. 10.1023/A:1008978114650, 11190004.
3. Schultz BM, Freedman ML. Iron deficiency in the elderly. Baillieres Clin Haematol 1987, 1:291-313. 10.1016/S0950-3536(87)80004-5, 3322440.
4. Zhu YI, Haas JD. Iron depletion without anemia and physical performance in young women. Am J Clin Nutr 1997, 66:334-341.
5. Zhu YI, Haas JD. Altered metabolic response of iron-depleted nonanemic women during a 15-km time trial. J Appl Physiol 1998, 84:1768-1775.
6. Vincent JL, Baron JF, Reinhart K, et al. Anemia and blood transfusion in critically ill patients. JAMA 2002, 288:1499-1507. 10.1001/jama.288.12.1499, 12243637.
7. Corwin HL, Gettinger A, Pearl RG, et al. The CRIT Study: Anemia and blood transfusion in the critically ill-current clinical practice in the United States. Crit Care Med 2004, 32:39-52. 10.1097/01.CCM.0000104112.34142.79, 14707558.
8. Piagnerelli M, Vincent JL. Role of iron in anaemic critically ill patients: it's time to investigate!. Crit Care 2004, 8:306-307. 10.1186/cc2884, 1065009, 15469585.
9. Darveau M, Denault AY, Blais N, Notebaert E. Bench-to-bedside review: iron metabolism in critically ill patients. Crit Care 2004, 8:356-362. 10.1186/cc2862, 1065005, 15469598.
10. Pieracci FM, Barie PS. Diagnosis and management of iron-related anemias in critical illness. Crit Care Med 2006, 34:1898-1905. 10.1097/01.CCM.0000220495.10510.C1, 16691135.
11. Nicolas G, Chauvet C, Viatte L, et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 2002, 110:1037-1044. 151151, 12370282.
12. Hentze MW, Muckenthaler MU, Galy B, Camaschella C. Two to tango: regulation of Mammalian iron metabolism. Cell 2010, 142:24-38. 10.1016/j.cell.2010.06.028, 20603012.
13. Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004, 306:2090-2093. 10.1126/science.1104742, 15514116.
14. Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004, 113:1271-1276. 398432, 15124018.
15. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005, 352:1011-1023. 10.1056/NEJMra041809, 15758012.
16. Andrews NC. Anemia of inflammation: the cytokine-hepcidin link. J Clin Invest 2004, 113:1251-1253. 398435, 15124013.
17. Ramsay AJ, Hooper JD, Folgueras AR, Velasco G, Lopez-Otin C. Matriptase-2 (TMPRSS6): a proteolytic regulator of iron homeostasis. Haematologica 2009, 94:849-849.
18. Pak M, Lopez MA, Gabayan V, Ganz T, Rivera S. Suppression of hepcidin during anemia requires erythropoietic activity. Blood 2006, 108:3730-3735. 10.1182/blood-2006-06-028787, 1895477, 16882706.
19. Vokurka M, Krijt J, Sulc K, Necas E. Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis. Physiol Res 2006, 55:667-674.
20. Tanno T, Bhanu NV, Oneal PA, et al. High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat Med 2007, 13:1096-1101. 10.1038/nm1629, 17721544.
21. Hill SR, Carless PA, Henry DA, et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Dat Syst Rev 2002, CD002042.
22. Walsh TS, Lee RJ, Maciver CR, et al. Anemia during and at discharge from intensive care: the impact of restrictive blood transfusion practice. Intensive Care Med 2006, 32:100-109. 10.1007/s00134-005-2855-2, 16328221.
23. Bateman AP, McArdle F, Walsh TS. Time course of anemia during six months follow up following intensive care discharge and factors associated with impaired recovery of erythropoiesis. Crit Care Med 2009, 37:1906-1912. 10.1097/CCM.0b013e3181a000cf, 19384207.
24. Corwin HL, Krantz SB. Anemia of the critically ill: "acute" anemia of chronic disease. Crit Care Med 2000, 28:3098-3099. 10.1097/00003246-200008000-00079, 10966311.
25. van Iperen CE, Gaillard CA, Kraaijenhagen RJ, Braam BG, Marx JJ, van de Wiel A. Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients. Crit Care Med 2000, 28:2773-2778. 10.1097/00003246-200008000-00015, 10966249.
26. von Ahsen N, Muller C, Serke S, Frei U, Eckardt KU. Important role of nondiagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients. Crit Care Med 1999, 27:2630-2639. 10.1097/00003246-199912000-00005, 10628602.
27. Wisser D, van Ackern K, Knoll E, Wisser H, Bertsch T. Blood loss from laboratory tests. Clin Chem 2003, 49:1651-1655. 10.1373/49.10.1651, 14500590.
28. Looker AC, Dallman PR, Carroll MD, Gunter EW, Johnson CL. Prevalence of iron deficiency in the United States. JAMA 1997, 277:973-976. 10.1001/jama.277.12.973, 9091669.
29. Smieja MJ, Cook DJ, Hunt DL, Ali MA, Guyatt GH. Recognizing and investigating iron-deficiency anemia in hospitalized elderly people. CMAJ 1996, 155:691-696. 1335221, 8823214.
30. Jankowska EA, Rozentryt P, Witkowska A, et al. Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur Heart J 2010, 31:1872-1880. 10.1093/eurheartj/ehq158, 20570952.
31. Bellamy MC, Gedney JA. Unrecognised iron deficiency in critical illness. Lancet 1998, 352:1903. 10.1016/S0140-6736(98)00088-9, 9863790.
32. Fernandez R, Tubau I, Masip J, Munoz L, Roig I, Artigas A. Low reticulocyte hemoglobin content is associated with a higher blood transfusion rate in critically ill patients: a cohort study. Anesthesiology 2010, 112:1211-1215. 10.1097/ALN.0b013e3181d74f87, 20418700.
33. Huang H, Constante M, Layoun A, Santos MM. Contribution of STAT3 and SMAD4 pathways to the regulation of hepcidin by opposing stimuli. Blood 2009, 113:3593-3599. 10.1182/blood-2008-08-173641, 2891008, 19204324.
34. Lasocki S, Millot S, Andrieu V, et al. Phlebotomies or erythropoietin injections allow mobilization of iron stores in a mouse model mimicking intensive care anemia. Crit Care Med 2008, 36:2388-2394. 10.1097/CCM.0b013e31818103b9, 18664788.
35. Theurl I, Aigner E, Theurl M, et al. Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. Blood 2009, 113:5277-5286. 10.1182/blood-2008-12-195651, 19293425.
36. Kroot JJ, Kemna EH, Bansal SS, et al. Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization. Haematologica 2009, 94:1748-1752. 10.3324/haematol.2009.010322, 2791950, 19996119.
37. Cheng PP, Jiao XY, Wang XH, Lin JH, Cai YM. Hepcidin expression in anemia of chronic disease and concomitant iron-deficiency anemia. Clin Exp Med
38. Lasocki S, Baron G, Driss F, et al. Diagnostic accuracy of serum hepcidin for iron deficiency in critically ill patients with anemia. Intensive Care Med 2010, 36:1044-1048. 10.1007/s00134-010-1794-8, 20213069.
39. Zarychanski R, Turgeon AF, McIntyre L, Fergusson DA. Erythropoietin-receptor agonists in critically ill patients: a meta-analysis of randomized controlled trials. CMAJ 2007, 177:725-734. 1976638, 17823140.
40. Brutsaert TD, Hernandez-Cordero S, Rivera J, Viola T, Hughes G, Haas JD. Iron supplementation improves progressive fatigue resistance during dynamic knee extensor exercise in iron-depleted, nonanemic women. Am J Clin Nutr 2003, 77:441-448.
41. Anker SD, Comin Colet J, Filippatos G, et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 2009, 361:2436-2448. 10.1056/NEJMoa0908355, 19920054.
42. Javadi P, Buchman TG, Stromberg PE, et al. High-dose exogenous iron following cecal ligation and puncture increases mortality rate in mice and is associated with an increase in gut epithelial and splenic apoptosis. Crit Care Med 2004, 32:1178-1185. 10.1097/01.CCM.0000124878.02614.4C, 15190970.
43. Driss F, Vrtovsnik F, Katsahian S, et al. Effects of intravenous polymaltose iron on oxidant stress and non-transferrin-bound iron in hemodialysis patients. Nephron Clin Pract 2005, 99:c63-c67. 10.1159/000083208, 15640610.
44. Marx JJ. Iron and infection: competition between host and microbes for a precious element. Best Pract Res Clin Haematol 2002, 15:411-426.
45. Hoen B, Paul-Dauphin A, Kessler M. Intravenous iron administration does not significantly increase the risk of bacteremia in chronic hemodialysis patients. Clin Nephrol 2002, 57:457-461.
46. Dallman PR. Iron deficiency and the immune response. Am J Clin Nutr 1987, 46:329-334.
47. Auerbach M, Ballard H, Glaspy J. Clinical update: intravenous iron for anaemia. Lancet 2007, 369:1502-1504. 10.1016/S0140-6736(07)60689-8, 17482969.
48. Notebaert E, Chauny JM, Albert M, Fortier S, Leblanc N, Williamson DR. Short-term benefits and risks of intravenous iron: a systematic review and meta-analysis. Transfusion 2007, 47:1905-1918. 10.1111/j.1537-2995.2007.01415.x, 17880619.
49. Pieracci FM, Henderson P, Rodney JR, et al. Randomized, double-blind, placebo-controlled trial of effects of enteral iron supplementation on anemia and risk of infection during surgical critical illness. Surg Infect (Larchmt) 2009, 10:9-19. 10.1089/sur.2008.043, 19245362.